Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh,  Oppenheimer & Co. Inc. (EP.94) episode artwork

EPISODE · Sep 7, 2021 · 38 MIN

Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94)

from BioTalk with Rich Bendis

Dr. Xavier Barril, Chief Scientific Officer, Gain Therapeutics, and Hartaj Singh, Managing Director and Senior Analyst, Oppenheimer & Co. Inc., Join BioTalk to discuss Artificial Intelligence and Machine Learning in Drug Discovery, and Wall Street's Views on this Exciting Science.

Episode metadata supplied by the publisher feed · Published Sep 7, 2021

Embed this episode

NOW PLAYING

Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94)

0:00 38:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of BioTalk with Rich Bendis?

This episode is 38 minutes long.

When was this BioTalk with Rich Bendis episode published?

This episode was published on September 7, 2021.

Can I download this BioTalk with Rich Bendis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!